(VXZ) iPath Series SP500 VIX - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US06746P6135
VXZ: ETN, Futures Contracts, Mid-Term Futures, Volatility Index, Exposure
The iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) is designed to give investors exposure to the mid-term futures contracts on the CBOE Volatility Index (VIX), allowing them to capitalize on the volatility of the S&P 500 index. By investing in VXZ, investors are essentially taking a position on the markets expectation of future volatility, as reflected in the prices of VIX futures contracts with maturities between 4-7 months.
To understand the ETNs behavior, its essential to recognize that its tied to the performance of VIX futures contracts, not the VIX index itself. This distinction is crucial because the futures contracts can diverge from the spot VIX index due to factors like contango and backwardation. As a result, VXZs price movements may not perfectly mirror the VIX index, and investors should be aware of this discrepancy when using VXZ as a volatility proxy.
Analyzing the
Combining the insights from
Based on this analysis, a potential trading strategy could involve buying VXZ on dips towards the 52-week low, targeting a price around 60-62, with a stop-loss below 47.79. Conversely, if VXZ breaks above the 52-week high, it may be a sign of increased volatility, and a long position could be considered, targeting a higher price level.
Additional Sources for VXZ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
VXZ ETF Overview
Market Cap in USD | 37m |
Category | Trading--Miscellaneous |
TER | 0.89% |
IPO / Inception | 2018-01-17 |
VXZ ETF Ratings
Growth Rating | -50.8 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 5.04 |
Analysts | - |
Fair Price Momentum | 49.60 USD |
Fair Price DCF | - |
VXZ Dividends
Currently no dividends paidVXZ Growth Ratios
Growth Correlation 3m | -41% |
Growth Correlation 12m | 60.9% |
Growth Correlation 5y | -90% |
CAGR 5y | -15.18% |
CAGR/Max DD 5y | -0.23 |
Sharpe Ratio 12m | 0.06 |
Alpha | 30.54 |
Beta | -1.597 |
Volatility | 24.72% |
Current Volume | 4.7k |
Average Volume 20d | 7.8k |
As of July 01, 2025, the stock is trading at USD 58.46 with a total of 4,716 shares traded.
Over the past week, the price has changed by -2.78%, over one month by -1.50%, over three months by +6.02% and over the past year by +20.49%.
No, based on ValueRay´s Analyses, iPath Series SP500 VIX (BATS:VXZ) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -50.80 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VXZ is around 49.60 USD . This means that VXZ is currently overvalued and has a potential downside of -15.16%.
iPath Series SP500 VIX has no consensus analysts rating.
According to our own proprietary Forecast Model, VXZ iPath Series SP500 VIX will be worth about 53.6 in July 2026. The stock is currently trading at 58.46. This means that the stock has a potential downside of -8.36%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 53.6 | -8.4% |